Having trouble accessing articles? Reset your cache.

Orion, Sun Pharmaceutical, Wockhardt neurology, generics news

Orion granted Sun and Wockhardt rights to market generic versions of Stalevo levodopa/carbidopa/entacapone to settle separate patent infringement suits between Orion and the other companies.

Read the full 253 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE